Table 4.

Accessibility, type, and administration schedule of rabies vaccine when needed for postexposure prophylaxis (PEP) of Peace Corps volunteers (PCVs) in 2011, by region

	West, Central, and East Africa	Eastern Europe and Northern Asia	Tropical South America	Mexico, Central America, and Caribbean	East and Southeast Asia	North Africa and Middle East	Southern Africa	Indian Ocean	Total
In your clinic in 2011, how often was rabies vaccine accessible* when it was needed for PCVs?
Number of responses	12	6	4	5	3	2	2	1	35
Never, n (%)	0 (0)	0 (0)	1 (25)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (2.9)
Seldom, n (%)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (50)	0 (0)	0 (0)	1 (2.9)
Sometimes, n (%)	1 (8.3)	0 (0)	0 (0)	1 (20)	0 (0)	0 (0)	0 (0)	0 (0)	2 (5.7)
Often, n (%)	0 (0)	0 (0)	0 (0)	1 (20)	0 (0)	0 (0)	0 (0)	0 (0)	1 (2.9)
Always, n (%)	11 (92)	6 (100)	3 (75)	3 (60)	3 (100)	1 (50)	2 (100)	1 (100)	30 (86)
In your clinic during 2011, what type of rabies vaccine was used as a part of PEP for rabies?
Number of responses	12	6	3	6	3	2	2	1	35
Human diploid cell, n (%)	3 (25)	2 (33)	0 (0)	1 (17)	0 (0)	0 (0)	0 (0)	0 (0)	6 (17)
Purified chick embryo cell, n (%)	0 (0)	1 (17)	0 (0)	0 (0)	1 (33)	0 (0)	0 (0)	0 (0)	2 (6)
Vero cell, n (%)	9 (75)	2 (33)	3 (100)	3 (50)	2 (67)	2 (100)	2 (100)	1 (100)	24 (69)
Other, n (%)	0 (0)	0 (0)	0 (0)	1 (17)	0 (0)	0 (0)	0 (0)	0 (0)	1 (2.9)
I don't know, n (%)	0 (0)	1 (17)	0 (0)	1 (17)	0 (0)	0 (0)	0 (0)	0 (0)	2 (5.7)
In your clinic during 2011, which rabies vaccine administration schedule did you typically prescribe for PEP?
Number of responses	12	6	3	5	3	2	2	1	34
4-dose intramuscular, n (%)	0 (0)	0 (0)	0 (0)	0 (0)	1 (33)	0 (0)	0 (0)	0 (0)	1 (2.9)
5-dose intramuscular, n (%)	0 (0)	4 (67)	0 (0)	0 (0)	0 (0)	1 (50)	0 (0)	0 (0)	5 (15)
2-dose intramuscular, n (%)	11 (92)	2 (33)	3 (100)	5 (100)	2 (67)	1 (50)	2 (100)	1 (100)	27 (79)
3-dose intramuscular, n (%)	1 (8.3)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (2.9)

^*“Accessible” was defined as available within 24 hours.